Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration
NCT ID: NCT02336958
Last Updated: 2015-03-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2013-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-guided Intermediate Cervical Plexus Block
NCT02794974
Analgesic Efficacy of Intermediate Cervical Plexus Block in Patients Undergoing Neck Surgeries: A Comparison Between Two Bupivacaine Concentrations
NCT06621836
Inter-semispinal Plane Block and Cervical Spine Surgery
NCT06003933
Influence of the Concentration of the Local Anesthetic Ropivacaine on the Quality of a Ultrasound Guided Intermediate Cervical Block.
NCT01759940
Medial Cervical Block for Carotid Endarterectomy Comparison With Standard Method
NCT01608126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Introduction of ultrasound guidance made it possible to guide the needle directly to the vascular wall. But this procedure is considered very demanding, because of guiding the needle in an anatomical region with artifacts (because of calcification), sudden movements (e.g. because of swallowing) and compromised coagulation (antithrombotic medication). On the other side there are no clinical data proving the benefit of an additional perivascular infiltration with local anesthetic. Therefore, this investigation is testing the hypothesis, that an additional perivascular infiltration is associated with increased block quality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ropivacaine
Ultrasound guided intermediate cervical plexus block: 20ml ropivacaine 0.75%. Ultrasound guided perivascular/pericarotidal infiltration: 5ml ropivacaine 0.75%.
intermediate cervical plexus block ropivacaine
20ml ultrasound guided intermediate cervical plexus block.
pericarotidal infiltration (active comparator) ropivacaine
5ml ropivacaine 0.75% (active comparator): pericarotidal infiltration.
jugular infiltration prilocaine
5ml prilocaine 1% jugular infiltration for wound drainage.
saline
Ultrasound guided intermediate cervical plexus block: 20ml ropivacaine 0.75%. Ultrasound guided perivascular/pericarotidal infiltration: 5ml saline 0.9%.
intermediate cervical plexus block ropivacaine
20ml ultrasound guided intermediate cervical plexus block.
jugular infiltration prilocaine
5ml prilocaine 1% jugular infiltration for wound drainage.
pericarotidal infiltration (placebo comparator) saline
5ml saline 0.9% (placebo comparator): pericarotidal infiltration.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intermediate cervical plexus block ropivacaine
20ml ultrasound guided intermediate cervical plexus block.
pericarotidal infiltration (active comparator) ropivacaine
5ml ropivacaine 0.75% (active comparator): pericarotidal infiltration.
jugular infiltration prilocaine
5ml prilocaine 1% jugular infiltration for wound drainage.
pericarotidal infiltration (placebo comparator) saline
5ml saline 0.9% (placebo comparator): pericarotidal infiltration.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adult patients (18 years or older)
* ASA-risk-groups I-IV
* informed consent
Exclusion Criteria
* pregnancy, lactation period
* participation in other studies
* addiction to drugs or alcohol
* non-cooperative patients
* no approval to regional anesthesia
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helios Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.med.Ronald Seidel
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ronald Seidel, Dr.med.
Role: PRINCIPAL_INVESTIGATOR
Helios Kliniken Schwerin, Klinik für Anästhesiologie und Intensivtherapie, Wismarsche Strasse 393-7, 19049 Schwerin, Germany
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A 2013-0075
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.